| P50 | author | Xin-Yuan Guan | Q39845550 |
| | Yunfei Yuan | Q40548428 |
| | Jian-Dong Huang | Q70624280 |
| | Jinna Chen | Q96128102 |
| | Lingxi Jiang | Q97533874 |
| P2093 | author name string | Yun Zhu | |
| | Shuo Fang | |
| | Tengfei Liu | |
| | Tingting Cao | |
| | Liyi Zhang | |
| | Xiaoyan Ming | |
| | Xuming Tang | |
| P2860 | cites work | RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase | Q24310179 |
| | The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death | Q28204906 |
| | Lymphocyte transformation by Pim-2 is dependent on nuclear factor-kappaB activation | Q28293962 |
| | The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor | Q28508632 |
| | Nuclear factor-kappaB in cancer development and progression | Q29547879 |
| | Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression | Q29615766 |
| | Epidemiology of viral hepatitis and hepatocellular carcinoma | Q29617918 |
| | PIM2 Induced COX-2 and MMP-9 expression in macrophages requires PI3K and Notch1 signaling | Q33418594 |
| | PIM kinase inhibitor AZD1208 for treatment of MYC-driven prostate cancer | Q35078578 |
| | The Pim kinases control rapamycin-resistant T cell survival and activation | Q36402605 |
| | Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma | Q37198014 |
| | Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity | Q37524210 |
| | AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia | Q37564783 |
| | Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation | Q38266874 |
| | Loss of PIM2 enhances the anti-proliferative effect of the pan-PIM kinase inhibitor AZD1208 in non-Hodgkin lymphomas. | Q38813901 |
| | PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy | Q38968271 |
| | Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma. | Q38999733 |
| | Allele-specific imbalance of oxidative stress-induced growth inhibitor 1 associates with progression of hepatocellular carcinoma. | Q39034955 |
| | Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival | Q39141546 |
| | The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells | Q39562043 |
| | Pim-2 activates API-5 to inhibit the apoptosis of hepatocellular carcinoma cells through NF-kappaB pathway | Q39788679 |
| | Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. | Q40049355 |
| | Identification of a regulatory autophosphorylation site in the serine-threonine kinase RIP2. | Q40258219 |
| | Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival | Q41868647 |
| | PhosphoNetworks: a database for human phosphorylation networks | Q42129105 |
| | Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. | Q43139836 |
| | Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region | Q45796591 |
| | Maelstrom promotes hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition by way of Akt/GSK-3β/Snail signaling. | Q47821487 |
| | SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice. | Q53263915 |
| | Hepatocellular carcinoma | Q73328021 |
| | Epidemiology of hepatocellular carcinoma | Q73541726 |
| P433 | issue | 7 | |
| P921 | main subject | NF-κB | Q411114 |
| | hepatocellular carcinoma | Q1148337 |
| P304 | page(s) | 510 | |
| P577 | publication date | 2020-07-02 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway | |
| P478 | volume | 11 | |